Stay updated on Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The Taiwan site listing was renamed from Taoyuan District to Taoyuan with the same postal code, updating the locations table to reflect current administrative naming.
    Difference
    0.0%
    Check dated 2026-05-07T22:25:12.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s revision label was updated from v3.5.2 to v3.5.3, signaling a small software revision of the ClinicalTrials.gov page.
    Difference
    0.0%
    Check dated 2026-04-30T16:47:44.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:33:27.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The location entry 'Padua, Italy, 35128' was updated to 'Padova, Italy, 35128' in the study locations.
    Difference
    0.0%
    Check dated 2026-04-09T08:09:41.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Replaced Napoli, Italy, 80131 with Naples, Italy, 80131 in the study locations.
    Difference
    0.0%
    Check dated 2026-03-25T20:19:44.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T12:13:16.000Z thumbnail image

Stay in the know with updates to Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page.